2015
DOI: 10.1007/s10439-015-1511-4
|View full text |Cite
|
Sign up to set email alerts
|

Mesoscopic Fluorescence Molecular Tomography for Evaluating Engineered Tissues

Abstract: Optimization of regenerative medicine strategies includes the design of biomaterials, development of cell-seeding methods, and control of cell-biomaterial interactions within the engineered tissues. Among these steps, one paramount challenge is to non-destructively image the engineered tissues in their entirety to assess structure, function, and molecular expression. It is especially important to be able to enable cell phenotyping and monitor the distribution and migration of cells throughout the bulk scaffold… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
43
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 43 publications
(43 citation statements)
references
References 78 publications
(114 reference statements)
0
43
0
Order By: Relevance
“…Depth-resolved LOT/FLOT has been demonstrated in imaging tumors/fluorescencelabeled tumors [13,15,16,40], perfused rat hearts [1], and fluorescence-labeled cells in tissue engineering [11,12], as well as for visualizing neural activities in mouse brain and spinal cord [6,8,41]. In a realistic experiment, usually we do not know the fluorescence situation/distribution of the sample, which means that it is difficult to choose a proper excitation power or exposure time for the unknown inhomogeneous fluorescence distribution.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Depth-resolved LOT/FLOT has been demonstrated in imaging tumors/fluorescencelabeled tumors [13,15,16,40], perfused rat hearts [1], and fluorescence-labeled cells in tissue engineering [11,12], as well as for visualizing neural activities in mouse brain and spinal cord [6,8,41]. In a realistic experiment, usually we do not know the fluorescence situation/distribution of the sample, which means that it is difficult to choose a proper excitation power or exposure time for the unknown inhomogeneous fluorescence distribution.…”
Section: Resultsmentioning
confidence: 99%
“…Soon after, LOT was rapidly adapted for fluorescent molecular imaging, which was termed either fluorescence laminar optical tomography (FLOT) [1,[5][6][7] or mesoscopic fluorescence molecular tomography (MFMT) [10,11], and several improvements or alternative system designs were investigated [5,6,[10][11][12][13][14]. FLOT has been reported to quantify depth-resolved distribution of fluorescence-labeled tumors [13,15,16], to image fluorescence-labeled cells in tissue engineering [11,12,16], and to visualize neural activities in mouse brains in vivo [6,17]. In the FLOT system configuration, a charge-coupled device (CCD) or electronmultiplying CCD (EMCCD) can be used as the array detector since either one has a higher sampling density in comparison to a photomultiplier tube (PMT) array or an avalanche photodiode (APD) array [6,16].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…LOT imaging of skin cancer based on absorption contrast has been demonstrated [46]. Fluorescence-based LOT (FLOT) has the potential to quantify depth-resolved distribution of fluorescence-labeled tumor [47][48][49][50].…”
Section: Introductionmentioning
confidence: 99%